DUBLIN, May 29, 2023 /PRNewswire/ — The “Antivenoms: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Antivenoms Market to Reach $2.3 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Antivenoms estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size … Read more
LONDON, May 29, 2023 /PRNewswire/ — Pains or aches can be a resultant of injuries, diseases, muscle or bone related issues, among others. Frequent aches disrupt our quality of life and prevents us from doing several things. Pain relief therapeutics have played a significant role in improving the quality of life for countless individuals worldwide. … Read more
TAMPA, Fla., May 29, 2023 /PRNewswire/ — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval for the Company’s Sirolimus coated balloon. The Company has … Read more
Small business owners, including owners of MSPs, are disproportionately affected when it comes to mental health issues, but few seek help. 65% of entrepreneurs have dealt with anxiety. 4 out of 5 small business owners are experiencing poor mental health. The SuperOps.ai #TogetherWeCan initiative sets out to support MSPs, let them know they are not … Read more
SAN DIEGO, May 29, 2023 /PRNewswire/ — Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders announced the award of a Fast Track Phase I/II STTR grant from the NIH-NIAMS. This highly competitive grant will provide substantial funding for the advancement of AMP-201, an AAV-ColQ gene … Read more
OSAKA, Japan, May 29, 2023 /PRNewswire/ — RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting. Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus. Collaborators also reported that S/F-iTregs generated … Read more
Porustobart in combination of toripalimab showed promising anti-tumor activity Porustobart in combination of toripalimab showed acceptable safety profile in HCC Porustobart in combination of toripalimab showed favorable PK/PD signature CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, May 28, 2023 /PRNewswire/ — Harbour BioMed (the “Company”, HKEX: 02142), a global biopharmaceutical company committed to the discovery, … Read more
TORONTO, May 27, 2023 /PRNewswire/ — Cora Therapeutics, a dynamic life sciences startup based in Toronto, proudly unveils the results of a clinical trial at the Canadian Association of Interventional Radiologists (CAIR) annual meeting in Quebec City. Dr. Kieran Murphy MD, FRCPC, FSIR, Founder, Inventor, and CMO of Cora Therapeutics, announced the efficacy of a … Read more
ORSERDU (elacestrant) foi aprovado em janeiro de 2023 pelo FDA para câncer de mama avançado ou metastático positivo para receptor de estrogênio (ER), receptor 2 do fator de crescimento epidérmico humano (HER2) negativo com mutações ESR1 (ESR1-mut), que são encontradas em até 40% dos tumores Em pacientes cujos tumores abrigam ESR1-mut, uma análise post-hoc anterior … Read more
Individuals with more underlying chronic health conditions were more likely to delay or avoid medical care OAKLAND, Calif., May 26, 2023 /PRNewswire/ — At the height of the pandemic, individuals were asked to delay preventive care and elective procedures to alleviate incidences of community transmission. Many employers are now understandably concerned about the costs of … Read more